allergan inc (AGN:New York)
Scott M. Whitcup M.D.
Chief Scientific Officer and Executive Vice President of Research & Development, Allergan Inc.
|Age||Total Calculated Compensation||This person is connected to 54 board members in 3 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Scott M. Whitcup, M.D. has been the Chief Scientific Officer of Allergan Inc. since April 2009 and has also been its Executive Vice President of Research and Development since July 28, 2004. Dr. Whitcup is responsible for Allergan's drug discovery efforts as well as the ophthalmology, Botox(R)/neurology, skin care and new technology development programs worldwide. He joined Allergan in January 2000 as Vice President of Development and Ophthalmology. He served as ...
2525 Dupont DrivePhone: 714-246-4500
Irvine, California 92612
Board Members Memberships*
Former Director, Chairman of Science Committee, Member of Executive Committee and Member of Corporate Governance Committee
Director, Chairman of Compliance Committee and Chairman of Science Committee
Weill Cornell Medical College, New York
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Brenton L. Saunders J.D.||Chief Executive Officer, President and Director|
|Dilip Shantilal Shanghvi||Managing Director, Executive Director and Member of Shareholders/Investors Grievance Committee|
Sun Pharmaceutical Industries Limited
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|--||Compensation as of Fiscal Year 2013.|